We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

19 hedge funds and large institutions have $22.3M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+19
Holders Change %
–
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$5.87M
2
PCM
Pentwater Capital Management
Florida
+$4.31M
3
Jennison Associates
Jennison Associates
New York
+$3.59M
4
JP Morgan Chase
JP Morgan Chase
New York
+$3.44M
5
DM
Deerfield Management
New York
+$2.56M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$5.57M +$5.87M +1,021,600 New
PCM
2
Pentwater Capital Management
Florida
$4.09M +$4.31M +750,000 New
Jennison Associates
3
Jennison Associates
New York
$3.41M +$3.59M +625,000 New
JP Morgan Chase
4
JP Morgan Chase
New York
$3.27M +$3.44M +600,000 New
DM
5
Deerfield Management
New York
$2.43M +$2.56M +446,452 New
DA
6
DSC Advisors
Illinois
$1.18M +$1.24M +215,896 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$995K +$1.05M +182,609 New
SM
8
Senvest Management
New York
$382K +$402K +70,000 New
Federated Hermes
9
Federated Hermes
Pennsylvania
$273K +$287K +50,000 New
Millennium Management
10
Millennium Management
New York
$188K +$198K +34,533 New
Deutsche Bank
11
Deutsche Bank
Germany
$177K +$187K +32,609 New
SIM
12
Spark Investment Management
New York
$109K +$114K +19,900 New
TRCT
13
Tower Research Capital (TRC)
New York
$89K +$94.1K +16,393 New
SIM
14
Strategic Investment Management
Virginia
$66K +$69.8K +12,151 New
Barclays
15
Barclays
United Kingdom
$29K +$32.7K +5,700 New
U
16
UBS
Switzerland
$13K +$13.8K +2,405 New
GSC
17
Ground Swell Capital
South Carolina
$4K +$4.59K +800 New
Morgan Stanley
18
Morgan Stanley
New York
$2K +$2.5K +436 New
SM
19
Sabby Management
Florida
$1.48K +$1.56M +271,200 New

FOMX Hedge Fund Activity: Q3 2014 in Review

19 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q3 2014, worth a combined $22.3M.

Buyers outnumbered sellers: 19 funds opened new FOMX positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $5.87M.

  • 19 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $22.3M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q3 2014.
  • 19 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q3 2014 and 0 closed out, a net change of +19 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q3 2014 was Baker Bros. Advisors, an estimated $5.87M added.

Based on aggregated 13F filings for Q3 2014.